BASKING RIDGE, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG), reports continued success of their international distribution partnership for the Resurgex(R) line of products in Greece. Since first delivering product to Nutrimedica in April 2006 overall sales in the Greek Market have increased approximately 40% from $30,000 in 2006 to $50,000 in 2007. A successful entry of a U.S. product into the Greek market depends on proper selection of a qualified distributor in Greece, which is knowledgeable of the local market and regulations. The distributor must be capable of developing a proper relationship with the distribution chain of medical institutions, practitioners and proper retail outlets in the medical marketplace. For the past 22 months Millennium has working with Nutrimedica, a well known distributor of nutritional products, in Athens. It has already imported and distributed Resurgex(R) products to hospitals, pharmacies, and direct to patients. Nutrimedica reports that the introduction of Resurgex products has been well received and sales have been steadily increasing. The steady growth has been encouraging due to the fact that no marketing dollars have been allocated to build brand awareness in the marketplace.
Millennium's three proprietary, marketed products, which form the
Company's Resurgex(R) Continuum of Care, include Resurgex Select(R),
Resurgex(R), and Resurgex Plus(R). Resurgex Select(R) is a whole
foods-based, calorically dense, high-protein nutritional formula developed
for cancer patients undergoing chemotherapy or radiation treatments.
Resurgex(R) and Resurgex Plus(R) are specialized, anabolic nutritional
supplements rich in antioxidants that provide nutritional support
post-treatment. Millennium is also recently developed a Surgex(R) sports
nutrition formula, clinically proven to address t
|SOURCE Millennium Biotechnologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved